Cathrine Fonnesbech Hjorth (Cathrine F Hjorth)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Cancer chemotherapy and pharmacology

Clinical epidemiology

Breast cancer research and treatment

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Aalborg Universitet Det Sundhedsvidenskabelige Fakultet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aalborg Universitet Det Sundhedsvidenskabelige Fakultet Feb 15 2016

Denmark

Research Assistant :: Deaprtment of health science and technology

Publications

Julie A Schmidt, Cathrine Fonnesbech Hjorth, Dóra Körmendiné Farkas, Per Damkier, Søren Feddersen, Stephen Jacques Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Thomas Patrick Ahern, Deirdre P Cronin-Fenton
Genetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort study. Breast cancer research and treatment (2024)
Julie A Schmidt, Kirsten M Woolpert, Cathrine Fonnesbech Hjorth, Dóra K Farkas, Bent Ejlertsen, Deirdre P Cronin-Fenton
Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology 91 (2) (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology 91 (2) (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology 91 (2) (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology 91 (2) (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L Lash, Henrik Bøggild, Henrik T Sørensen, Deirdre Cronin-Fenton
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer. Cancer chemotherapy and pharmacology 91 (2) (2023)
Cathrine Fonnesbech Hjorth, Per Damkier, Tore B Stage, Søren Feddersen, Stephen Hamilton-Dutoit, Mikael Rørth, Bent Ejlertsen, Timothy L Lash, Thomas P Ahern, Henrik T Sørensen, Deirdre Cronin-Fenton
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast cancer research and treatment 194 (2) (2022)
Signe Sørup, Bianka Darvalics, Jakob Schöllhammer Knudsen, Anne Staub Rasmussen, Cathrine Fonnesbech Hjorth, Søren Viborg Vestergaard, Azza Ahmed Khalil, Leo Russo, Dina Oksen, Emmanuelle Boutmy, Patrice Verpillat, Mikael Rørth, Deirdre P Cronin-Fenton
Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital. Clinical epidemiology 14 (2022)
Cathrine Fonnesbech Hjorth, Per Damkier, Bent Ejlertsen, Timothy Lash, Henrik Toft Sørensen, Deirdre Cronin-Fenton
Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark. BMC medicine 19 (1) (2021)
Nina Gran Egeland, Kristin Jonsdottir, Kristina Lystlund Lauridsen, Ivar Skaland, Cathrine Fonnesbech Hjorth, Einar G Gudlaugsson, Stephen Jacques Hamilton-Dutoit, Timothy L Lash, Deirdre P Cronin-Fenton, Emilius A M Janssen
Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients. Clinical epidemiology 12 (2020)
Cathrine Fonnesbech Hjorth, Anja S Nielsen, Henrik Toft Sorensen, Timothy L Lash, Per Damkier, Stephen Jacques Hamilton-Dutoit, Deirdre P Cronin-Fenton
Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study. Acta oncologica (Stockholm, Sweden) 58 (2) (2018)

Cathrine Fonnesbech Hjorth.css-eqlu8i{font-size:small;padding-left:4px;} (Cathrine F Hjorth)

Publication Activity (10 Years)

Top Topics

Top Venues

Cathrine Fonnesbech Hjorth (Cathrine F Hjorth)